[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100602819":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":26,"centralContacts":39,"locations":50,"responsibleParty":72,"collaborators":44,"id":75,"slug":76,"hasResults":77,"nctId":78,"briefTitle":79,"officialTitle":80,"acronym":44,"eligibilityCriteria":81,"healthyVolunteers":82,"sex":83,"minAge":84,"maxAge":85,"enrollmentInfo":86,"targetDuration":44,"studyType":89,"phases":90,"briefSummary":92,"conditions":93,"keywords":44,"overallStatus":53,"whyStopped":44,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"South Valley University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients Group","ACTIVE_COMPARATOR","About 20 patients with psoriasis and psoriatic arthritis.",[13],"Drug: Humira",{"label":15,"type":10,"description":16,"interventionNames":17},"Healthy Group","About 20 healthy control group.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","Humira","Assess the response of psoriasis and psoriatic arthritis to Humira and also Assessing the pharmacogenetic association between IL 12B genetic polymorphism (rs3213094) in psoriatic and psoriatic arthritis patients taking Humira.",[15,9],[25],"IL 12B genetic polymorphism (rs3213094)",[27,31,35],{"name":28,"affiliation":29,"role":30},"Moustafa Adam Ali El Taieb, Professor","Dermatology, Venereology and Andrology. Faculty of Medicine,Qena University","STUDY_CHAIR",{"name":32,"affiliation":33,"role":34},"Eisa Mohammed Hegazy, Professor","Dermatology, Venereology and Andrology. Qena Faculty of Medicine,South Valley University","STUDY_DIRECTOR",{"name":36,"affiliation":37,"role":38},"Mohamed Hosny Hassan, Professor","Medical Biochemistry Department,Qena Faculty of Medicine,south valley university","PRINCIPAL_INVESTIGATOR",[40,46],{"name":41,"role":42,"phone":43,"phoneExt":44,"email":45},"Alaa Ahmed Saad Ali Aweida, MSc","CONTACT","+201119814470",null,"alaaahmed201666@gmail.com",{"name":47,"role":42,"phone":48,"phoneExt":44,"email":49},"Soheir Abdel-Hamid Ali, Lecturer","+201066877343","Soher.abdel-hamed@med.svu.edu.eg",[51],{"facility":52,"status":53,"city":54,"state":44,"zip":44,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"Qina University hospital, South Valley University Hospital","RECRUITING","Qina","Egypt","EG",{"type":58,"coordinates":59},"Point",[60,61],32.72671,26.16418,{"lat":61,"lon":60},[64,68],{"name":65,"role":42,"phone":66,"phoneExt":44,"email":67},"Ebtehal Alaa El-Din Kotop Mohamed, Lecturer","+201066798383","Ebtehal_alaa@med.svu.edu.eg",{"name":69,"role":42,"phone":70,"phoneExt":44,"email":71},"Shimaa Saber Ahmed, M.D","+201099283315","shimaasaber063@gmail.com",{"type":38,"investigatorFullName":73,"investigatorTitle":74,"investigatorAffiliation":5,"oldNameTitle":44,"oldOrganization":44},"Alaa Ahmed Saad Ali Aweida","Resident at Dermatology , venereology and andrology, Faculty of medicine","100602819","evaluation-of-il-12b-genetic-polymorphism-rs3213094-100602819",false,"NCT07128472","Evaluation of IL 12B Genetic Polymorphism (rs3213094)","Evaluation of IL 12B Genetic Polymorphism (rs3213094) in Patient With Psoriasis and Psoriatic Arthritis in Response to Humira","Inclusion Criteria:\n\n\\- Patients having psoriasis diagnosed clinically for at least 6 months and who have a severity grade of severe, defined as a Psoriasis Area and Severity Index (PASI) score greater than 10, and involvement of greater than 10% of the body surface area (BSA) with psoriatic arthritis.\n\nExclusion Criteria:\n\n* Patients with other autoimmune or inflammatory conditions (e.g., rheumatoid arthritis, lupus).\n* Pregnancy and lactation.\n* Patients currently undergoing any treatment other than Humira.\n* Patients with known genetic disorders affect immune system function.\n* Patients were undergoing any treatment other than Humira in the last 6 months.\n* Patients with active infections, including tuberculosis or chronic viral infections (e.g., hepatitis B or C, HIV).\n* Patients with contraindication to Humira.\n* Renal \\&Vascular diseases",true,"ALL","18 Years","70 Years",{"count":87,"type":88},40,"ESTIMATED","INTERVENTIONAL",[91],"NA","Psoriasis is a skin disorder that is chronic proliferative and inflammatory in nature. Extensor surfaces, scalp, and lumbosacral area are covered in erythematous plaques with silvery scales. The disease can also impair the eyes and joints. It has no cure. Because of their low quality of life, many psoriasis patients experience depression. In addition to the cutaneous manifestations, it is associated with an increased risk of psoriatic arthritis, depression and cardiovascular disease.",[94],"Psoriasis","2025-08-13",{"date":97,"type":98},"2025-08-19","ACTUAL",{"date":100,"type":98},"2025-08-01",{"date":102,"type":88},"2026-02-01",{"name":5,"class":6},1]